ENTITY
Innovent Biologics Inc

Innovent Biologics Inc (1801 HK)

516
Analysis
Health Care • China
Innovent Biologics, Inc. operates as a biopharmaceutical company. The Company develops, manufactures, and distributes monoclonal antibody drug candidates for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and other diseases. Innovent Biologics serves customers in China.
more
bullish•Yum China Holdings
•10 Nov 2025 16:52

Quiddity Leaderboard HSCEI Dec25: Three Index Change Possible; ~US$264mn One-Way; Announcement Soon

We continue to expect Yum China Holdings (9987 HK) to outperform Haidilao International Holding (6862 HK) over the next few weeks.

Share
bullish•Yum China Holdings
•04 Nov 2025 05:30

HSCEI Index Rebalance Preview: 3 Changes as Adds Go Up, Up & Away

There could be 3 changes for the HSCEI in Dec. Estimated turnover is 4% and round-trip trade is HK$5.15bn. Shorts have been covering in the...

Logo
1k Views
Share
bullish•Quantitative Analysis
•03 Nov 2025 11:30

Hong Kong Connect Flows (October): $792m Outflows from Healthcare

We estimated the inflows to Hong Kong stocks from mainland investors to be USD 11bn in October and noted outflows of $792m from Healthcare sector.

Logo
437 Views
Share
bullish•Quantitative Analysis
•02 Nov 2025 10:05

HK Connect Flows Weekly (Oct 31st): CNOOC, SMIC, Alibaba, China Mobile, CSPC Pharma, Tencent

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for CNOOC, SMIC, Alibaba, China Mobile, CSPC Pharma, Tencent,...

Logo
281 Views
Share
•27 Oct 2025 09:56

HK Connect SOUTHBOUND Flows (2wks To 24 Oct 2025); Big Flows on Downdraft, Lower Flows on Rebound

SOUTHBOUND volumes remain high. Higher in the downdraft than this past week's rebound, but still generically high. Net flows remain consistent even...

Logo
513 Views
Share
x